Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Developing Novel Diagnostic Tests To Improve Surveillance for Antimicrobial Resistant Pathogens, Funding Opportunity Announcement CI10-002; Initial Review, 26266 [2010-11189]
Download as PDF
<![CDATA[
26266
Federal Register / Vol. 75, No. 90 / Tuesday, May 11, 2010 / Notices
or before May 28, 2010. Time allotted
for each presentation may be limited. If
the number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by June 1, 2010.
Persons attending FDA’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Doreen Kezer
at least 7 days in advance of the
meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/
AdvisoryCommittees/AboutAdvisory
Committees/ucm111462.htm for
procedures on public conduct during
advisory committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: May 5, 2010.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
[FR Doc. 2010–11038 Filed 5–10–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
emcdonald on DSK2BSOYB1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Developing Novel
Diagnostic Tests To Improve
Surveillance for Antimicrobial
Resistant Pathogens, Funding
Opportunity Announcement CI10–002;
Initial Review
Correction: This notice was published
in the Federal Register on April 23,
2010, Volume 75, Number 78, page
21339. The time and date, and place
should read as follows:
Time and Date:
12 p.m.–3 p.m., May 18, 2010
(Closed).
Place: Teleconference.
Contact Person for More Information:
Gregory Anderson, M.S., M.P.H.,
VerDate Mar<15>2010
19:22 May 10, 2010
Jkt 220001
Scientific Review Officer, CDC, 1600
Clifton Road, NE., Mailstop E60,
Atlanta, GA 30333, Telephone: (404)
498–2293. The Director, Management
Analysis and Services Office, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: April 29, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–11189 Filed 5–10–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Safety and Occupational Health Study
Section (SOHSS), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times And Dates:
8 a.m.–5 p.m., June 22, 2010. (Closed).
8 a.m.–5 p.m., June 23, 2010. (Closed).
Place: Omni Hotel, 500 California
Street, San Francisco, California 94104,
Telephone (415) 677–9494, Fax (415)
273–3038.
Status: These portions of the meeting
will be closed to the public in
accordance with provisions set forth in
Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the
Director, Management Analysis and
Services Office, Centers for Disease
Control and Prevention, pursuant to
Section 10(d) Public Law 92–463.
Purpose: The Safety and Occupational
Health Study Section will review,
discuss, and evaluate grant
application(s) received in response to
the Institute’s standard grants review
and funding cycles pertaining to
research issues in occupational safety
and health, and allied areas.
It is the intent of NIOSH to support
broad-based research endeavors in
keeping with the Institute’s program
goals. This will lead to improved
understanding and appreciation for the
magnitude of the aggregate health
burden associated with occupational
injuries and illnesses, as well as to
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
support more focused research projects,
which will lead to improvements in the
delivery of occupational safety and
health services, and the prevention of
work-related injury and illness. It is
anticipated that research funded will
promote these program goals.
Matters to be Discussed: The meeting
will convene to address matters related
to the conduct of Study Section
business and for the study section to
consider safety and occupational healthrelated grant applications.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Price Connor, PhD., NIOSH Health
Scientist, 1600 Clifton Road, NE.,
Mailstop E–20, Atlanta, Georgia 30333,
Telephone (404) 498–2511, Fax (404)
498–2571.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both CDC and
the Agency for Toxic Substances and
Disease Registry.
Dated: April 29, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–11186 Filed 5–10–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute (NCI);
National Institute of Allergy and
Infectious Diseases (NIAID); National
Institute of Arthritis and
Musculoskeletal and Skin Diseases
(NIAMS); and Office of Research on
Women’s Health (ORWH), Office of the
Director (OD), NIH
AGENCY:
National Institutes of Health
(NIH).
ACTION:
Notice of Open Conference.
Notice is hereby given that the NIH,
an agency of the Department of Health
and Human Services, in collaboration
with the Lupus Foundation of America,
Washington, DC, will hold a scientific
conference.
Title: ‘‘Systemic Lupus
Erythematosus: From Mouse Models to
Human Disease and Treatment.’’
Dates: September 2–3, 2010.
Location: Lister Hill Auditorium,
Building 38A, NIH, Bethesda, Maryland.
E:\FR\FM\11MYN1.SGM
11MYN1
]]>Agencies
[Federal Register Volume 75, Number 90 (Tuesday, May 11, 2010)]
[Notices]
[Page 26266]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-11189]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel: Developing Novel Diagnostic Tests To Improve
Surveillance for Antimicrobial Resistant Pathogens, Funding Opportunity
Announcement CI10-002; Initial Review
Correction: This notice was published in the Federal Register on
April 23, 2010, Volume 75, Number 78, page 21339. The time and date,
and place should read as follows:
Time and Date:
12 p.m.-3 p.m., May 18, 2010 (Closed).
Place: Teleconference.
Contact Person for More Information: Gregory Anderson, M.S.,
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE.,
Mailstop E60, Atlanta, GA 30333, Telephone: (404) 498-2293. The
Director, Management Analysis and Services Office, has been delegated
the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: April 29, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2010-11189 Filed 5-10-10; 8:45 am]
BILLING CODE 4163-18-P
